Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 have?
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 has 128 citations in the OpenAlex counts ScholarIQ stores.
When was Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 published?
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 has 2020 year in the ScholarIQ index.
What is the open-access status of Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19?
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 has bronze oa status in the ScholarIQ index.
What is the DOI of Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19?
The DOI for Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 is on the source record.
What is the PMID of Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19?
The PMID for Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 is on the source record.
What is the OpenAlex record for Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19?
The OpenAlex for Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 is on the source record.